Close Menu

In Nature this week, a team led by researchers at St. Jude Children's Research Hospital report a novel therapy for retinoblastoma. The team performed genomic and epigenetic analyses of retinoblastoma samples, and found that the cancer's genome is stable, though several of its pathways can be deregulated. As the team reports, the only known cancer gene mutated in these tumors is RB1, and that the overall mutational rate is very low.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.